Infectious Diseases (except HIV/AIDS)
-
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
This article has 694 authors:Reviewed by ScreenIT
-
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity
This article has 6 authors:Reviewed by ScreenIT
-
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received
This article has 8 authors:Reviewed by ScreenIT
-
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
This article has 22 authors:Reviewed by ScreenIT
-
COVIDFast™: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab (SwabFAST™) or saliva (SalivaFAST™)
This article has 14 authors:Reviewed by ScreenIT
-
Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho
This article has 14 authors:Reviewed by ScreenIT
-
A Global Study on the Correlates of Gross Domestic Product (GDP) and COVID-19 Vaccine Distribution
This article has 8 authors:Reviewed by ScreenIT
-
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
This article has 36 authors:Reviewed by ScreenIT
-
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
This article has 41 authors:Reviewed by ScreenIT
-
Predicting the impact of COVID-19 vaccination campaigns – a flexible age-dependent, spatially-stratified predictive model, accounting for multiple viral variants and vaccines
This article has 4 authors:Reviewed by ScreenIT